首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2452494篇
  免费   201975篇
  国内免费   4320篇
耳鼻咽喉   35615篇
儿科学   76653篇
妇产科学   65917篇
基础医学   345888篇
口腔科学   69636篇
临床医学   221249篇
内科学   482996篇
皮肤病学   50384篇
神经病学   206834篇
特种医学   99417篇
外国民族医学   918篇
外科学   373798篇
综合类   57443篇
现状与发展   1篇
一般理论   999篇
预防医学   194661篇
眼科学   58114篇
药学   183358篇
  4篇
中国医学   4625篇
肿瘤学   130279篇
  2018年   24801篇
  2016年   21303篇
  2015年   24125篇
  2014年   34631篇
  2013年   52484篇
  2012年   70922篇
  2011年   74483篇
  2010年   43901篇
  2009年   42189篇
  2008年   71083篇
  2007年   75525篇
  2006年   76522篇
  2005年   74675篇
  2004年   71945篇
  2003年   69552篇
  2002年   68699篇
  2001年   116978篇
  2000年   120978篇
  1999年   102177篇
  1998年   28984篇
  1997年   26594篇
  1996年   26352篇
  1995年   25449篇
  1994年   23890篇
  1993年   22279篇
  1992年   81917篇
  1991年   78814篇
  1990年   76087篇
  1989年   73223篇
  1988年   67982篇
  1987年   66823篇
  1986年   63370篇
  1985年   60273篇
  1984年   45654篇
  1983年   38835篇
  1982年   23551篇
  1981年   21011篇
  1980年   19581篇
  1979年   42664篇
  1978年   30014篇
  1977年   25195篇
  1976年   23546篇
  1975年   24893篇
  1974年   30570篇
  1973年   28957篇
  1972年   27040篇
  1971年   24914篇
  1970年   23459篇
  1969年   21727篇
  1968年   19780篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
42.
43.
44.
45.
46.
47.
48.
Acne vulgaris (acne) is a chronic inflammatory disease of the sebaceous gland, characterized by follicular hyperkeratinization, excessive colonization by Propionibacterium acnes (Pacnes) as well as immune reactions and inflammation. Despite an armamentarium of topical treatments available including benzoyl peroxide, retinoids and azelaic acid, topical antibiotics in monotherapies, especially erythromycin and clindamycin, are still used in Europe to treat acne. This intensive use led to antimicrobial‐resistant P. acnes and staphylococci strains becoming one of the main health issues worldwide. This is an update on the current topical acne treatments available in Europe, their mechanism of action, their potential to induce antimicrobial resistance and their clinical efficacy and safety.  相似文献   
49.
50.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号